000 01696 a2200493 4500
005 20250515183750.0
264 0 _c20090917
008 200909s 0 0 eng d
022 _a1873-7064
024 7 _a10.1016/j.neuropharm.2009.01.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBourasset, Fanchon
245 0 0 _aReduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease.
_h[electronic resource]
260 _bNeuropharmacology
_cMar 2009
300 _a808-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlzheimer Disease
_xmetabolism
650 0 4 _aAmyloid beta-Peptides
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aBasement Membrane
_xmetabolism
650 0 4 _aBlood Vessels
_xmetabolism
650 0 4 _aBrain
_xpathology
650 0 4 _aBrain Chemistry
_xdrug effects
650 0 4 _aCerebrovascular Circulation
_xphysiology
650 0 4 _aCollagen Type I
_xmetabolism
650 0 4 _aCollagen Type IV
_xmetabolism
650 0 4 _aDiazepam
_xmetabolism
650 0 4 _aGABA Modulators
_xmetabolism
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _atau Proteins
_xmetabolism
700 1 _aOuellet, Mélissa
700 1 _aTremblay, Cyntia
700 1 _aJulien, Carl
700 1 _aDo, Tuan Minh
700 1 _aOddo, Salvatore
700 1 _aLaFerla, Frank
700 1 _aCalon, Frédéric
773 0 _tNeuropharmacology
_gvol. 56
_gno. 4
_gp. 808-13
856 4 0 _uhttps://doi.org/10.1016/j.neuropharm.2009.01.006
_zAvailable from publisher's website
999 _c19107358
_d19107358